Modified Insulin Most Effective for Controlling Post-Meal Blood Sugar Levels
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Modified Insulin Most Effective for Controlling Post-Meal Blood Sugar Levels

ROCKVILLE, Md -- September 17, 2008 -- Premixed insulin analogues are more effective than long-acting analogues for controlling high blood sugar levels after meals in patients with type 2 diabetes, according to report published online in the Annals of Internal Medicine.

The report represents a systematic review of 45 research studies and is intended to provide unbiased, evidence-based information so that clinicians and others can make the best possible treatment decisions.

"While it is clear that premixed insulin analogues offer certain advantages to patients with diabetes, what is good for one patient may not be good for another," said Carolyn M. Clancy, MD, Agency for Healthcare Research and Quality (AHRQ), Rockville, Maryland.

The AHRQ report compared premixed insulin analogues with conventional premixed human insulin, oral diabetes drugs, and 2 other kinds of insulin analogues -- long-acting and rapid-acting analogues.

The findings of the report include the following:
· Long-acting insulin analogues appear to be more effective than premixed insulin analogues in lowering fasting blood sugar levels.
· Premixed insulin analogues are better than long-acting analogues alone in lowering blood sugar levels after a meal with high sugar content.
· Premixed insulin analogues are more effective than long-acting analogues in lowering haemoglobin A1C, which is a highly reliable indicator of chronic high blood sugar.
· Premixed insulin analogues are more effective than noninsulin antidiabetic medications in lowering fasting blood sugar levels.
· Premixed insulin analogues are more likely than long-acting analogues to be associated with hypoglycaemia, and are similar to premixed human insulin preparations in terms of the frequency of hypoglycaemia reported.
· Premixed insulin analogues are associated with a higher frequency of hypoglycaemic events than oral antidiabetic agents are.

The complete report is available at: effectivehealthcare.ahrq.gov

SOURCE: Agency for Healthcare Research and Quality

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities